Mannitol is an osmotic diuretic that is freely filtered by the glomerulus but not reabsorbed by renal tubules. It works by increasing the osmolarity of renal tubular fluid and drawing fluid from intracellular to extracellular spaces. Main uses include prophylaxis of acute renal failure, treatment of acute oliguria and increased intracranial pressure. While it reduces ICP, mannitol provides limited benefit for oxygenation compared to hypertonic saline and risks cardiac failure and electrolyte imbalance with higher doses.
Mechanism of urine formation
Definition and classification of diuretics
MOA and SAR of each class
Their dose and adverse effects
Pharmacologicaol uses
all about diuretics
Mechanism of urine formation
Definition and classification of diuretics
MOA and SAR of each class
Their dose and adverse effects
Pharmacologicaol uses
all about diuretics
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
2. • Osmotic diuretic
– Freely filterable at glomerulus
– Ltd reabsorption fm renal tubules
– Resist metabolism
– Pharmacologically inert
• 6 carbon sugar
GEETANJALI S VERMA
3. • Doesn’t undergo metabolism
• Not absorbed from GIT
• Doesn’t enter cells
• Clearance from plasma by glomerular
filtration
GEETANJALI S VERMA
4. MOA
Completely filtered at glomeruli
↓
Increases osmolarity of renal tubular fluid
Prevents re absorption of water
↓
Na+ dilution in retained water
Less re absorption of Na+
↓
Urinary excretion of Na+, Cl-, HCO3-
(urinary pH not altered)
GEETANJALI S VERMA
6. Increases plasma osmolarity
↓
Draws fluid fm intra to extra cellular spaces
↓
Acute expansion of intravascular fluid volume
↓
Decreases brain bulk, increases renal blood flow
to medulla
GEETANJALI S VERMA
8. USES
1. Prophylaxis against acute renal failure
2. D/d of acute oliguria
3. T/t of increased ICP
4. To decreased IOP
GEETANJALI S VERMA
9. West J Med. 1979 October; 131(4): 277–284
• Allen R. Nissenson, MD, Raymond E. Weston, MD, and Charles R. Kleeman, MD
• Author information ► Copyright and License information ►
Abstract
• Mannitol may be useful clinically both as a diuretic and as an obligate extracellular
solute. As a diuretic it can be used to treat patients with intractable
edema states, to increase urine flow and flush out debris from the
renal tubules in patients with acute tubular necrosis, and to increase
toxin excretion in patients with barbiturate, salicylate or bromide
intoxication. As an obligate extracellular solute it may be useful to
ameliorate symptoms of the dialysis disequilibrium syndrome, to
decrease cerebral edema following trauma or cerebrovascular
accident, and to prevent cell swelling related to renal ischemia
following cross-clamping of the aorta. Largely unexplored uses for
mannitol include its use as an osmotic agent in place of dextrose in peritoneal
dialysis solutions, its use to maintain urine output in patients newly begun on
hemodialysis, and its use to limit infarct size following acute myocardial infarction.
GEETANJALI S VERMA
10. • Acute renal failure prophy
– After cardiovasc surg, transplantn, extensive
trauma, surg in jaundiced pt, nephrotoxic condn
– Van Valenberg et al , 1984 : ARF less in pts
receiving mannitol prior to revascularisation of
transplanted kidney
GEETANJALI S VERMA
11. • Diagnosis of acute oliguria
– 0.25g/kg IV
– Urine output increased = intravasc fluid vol
depletion
– No increase = glomerular/ renal tubular fn
compromised
GEETANJALI S VERMA
12. • t/t of increased ICP
– 0.25-1 g/kg
– Increases plasma osm – withdraws fluid fm brain
tissues
– Vasodil of vasc smooth muscle
– Decreases rate of formn of CSF
– Effective within 10-15mins of adm, lasts for 2hrs
– No rebound increase
GEETANJALI S VERMA
13. Bratton – J Neurotrauma - 2007
GEETANJALI S VERMA
15. Mannitol
… but
No oxygenation improvement compared to HS
Oddo – JNNP - 2009Sakowitz – J Trauma - 2007
Mannitol
PtiO2
PitO2:
- normal = 35 mm Hg
- Ischemic threshold < 10-15 mm Hg GEETANJALI S VERMA
16. NATO study
To prove non-inferiority of HS vs mannitol on brain metabolism
Sample size : 30 patients
15 mannitol (1 g/kg), 15 HS 7.5% (2 mL/kg)
Same osmotic load
Main objective : effects on lactate/pyruvate ratio (redox
potential)
Secondary objectives : effects on ICP, PtiO2, cerebral glucose
GEETANJALI S VERMA
18. • Reduction of IOP
– Increases plasma osm, withdraws fluid fm
intraocular space
GEETANJALI S VERMA
19. C/I
• Well established anuria due to severe renal disease.
• Severe pulmonary congestion or frank pulmonary edema.
• Active intracranial bleeding except during craniotomy.
• Severe dehydration.
• Progressive renal damage or dysfunction after institution of
mannitol therapy, including increasing oliguria and
azotemia.
• Progressive heart failure or pulmonary congestion after
institution of mannitol therapy.
• Do not administer to patients with a known hypersensitivity
to mannitol.
GEETANJALI S VERMA